FDA's Compounding Advisory Committee's Effects for Compounding Pharmacists

February 25, 2015

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA's Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how the FDA’s Compounding Advisory Committee will affect the daily practice of compounding pharmacists.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.